Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton.
Dale RC, Tantsis EM, Merheb V, Kumaran RY, Sinmaz N, Pathmanandavel K, Ramanathan S, Booth DR, Wienholt LA, Prelog K, Clark DR, Guillemin GJ, Lim CK, Mathey EK, Brilot F.
Dale RC, et al. Among authors: ramanathan s.
Neurol Neuroimmunol Neuroinflamm. 2014 May 22;1(1):e12. doi: 10.1212/NXI.0000000000000012. eCollection 2014 Jun.
Neurol Neuroimmunol Neuroinflamm. 2014.
PMID: 25340056
Free PMC article.